financetom
Business
financetom
/
Business
/
Atlassian Insider Sold Shares Worth $1,116,973, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Atlassian Insider Sold Shares Worth $1,116,973, According to a Recent SEC Filing
Aug 8, 2024 2:41 PM

05:16 PM EDT, 08/08/2024 (MT Newswires) -- Scott Farquhar, 10% Owner, Director, Co-CEO, Co-Founder, on August 07, 2024, sold 7,948 shares in Atlassian ( TEAM ) for $1,116,973. Following the Form 4 filing with the SEC, Farquhar has control over a total of 294,076 shares of the company, with 294,076 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1650372/000156218024006116/xslF345X03/primarydocument.xml

Price: 139.20, Change: +0.41, Percent Change: +0.30

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Outcrop Silver & Gold Extends High-Grade Intercepts at Santa Ana Project in Colombia
Outcrop Silver & Gold Extends High-Grade Intercepts at Santa Ana Project in Colombia
Sep 3, 2025
09:58 AM EDT, 09/03/2025 (MT Newswires) -- Outcrop Silver & Gold ( OCGSF ) rose 6.9% Wednesday after reporting new high-grade intercepts from the Guadual vein at its 100%-owned Santa Ana silver project in Colombia. The company said multiple drill holes intersected high-grade mineralization, confirming strike and depth continuity in the Guadual North vein system, which remains open in all...
Update: Dollar Tree Fiscal Q2 Adjusted Earnings, Revenue Rise; Full-Year Outlook Updated; Shares Fall
Update: Dollar Tree Fiscal Q2 Adjusted Earnings, Revenue Rise; Full-Year Outlook Updated; Shares Fall
Sep 3, 2025
09:59 AM EDT, 09/03/2025 (MT Newswires) -- (Updates with the latest stock movement in headline and last paragraph) Dollar Tree ( DLTR ) reported fiscal Q2 adjusted earnings from continuing operations Wednesday of $0.77 per diluted share, up from $0.68 a year earlier. Analysts polled by FactSet expected $0.42. Revenue for the quarter ended Aug. 2 was $4.57 billion, compared...
Update: Macy's Shares Rise After Better-Than-Expected Fiscal Q2 Results, 2025 Guidance Boost
Update: Macy's Shares Rise After Better-Than-Expected Fiscal Q2 Results, 2025 Guidance Boost
Sep 3, 2025
09:56 AM EDT, 09/03/2025 (MT Newswires) -- (Updates with the latest stock movement in the headline and the first paragraph.) Macy's (M) shares were up 21% in recent Wednesday trading after the company posted fiscal Q2 adjusted earnings and net sales that topped analyst estimates and raised its fiscal 2025 outlook. The company reported fiscal Q2 adjusted earnings Wednesday of...
Genmab Says Outpatient Epcoritamab Treatment Feasible in Phase 2 Study
Genmab Says Outpatient Epcoritamab Treatment Feasible in Phase 2 Study
Sep 3, 2025
09:59 AM EDT, 09/03/2025 (MT Newswires) -- Genmab ( GMAB ) said Wednesday that updated results from its phase 2 trial of epcoritamab in adults with relapsed and refractory diffuse large B-cell lymphoma demonstrated the feasibility of treating and monitoring patients in an outpatient setting after the first dose. The study also showed that epcoritamab's adverse event profile and efficacy...
Copyright 2023-2026 - www.financetom.com All Rights Reserved